Chlamydial infections (third of three parts).

PubWeight™: 9.21‹?› | Rank: Top 0.1%

🔗 View Article (PMID 342952)

Published in N Engl J Med on March 09, 1978

Authors

J Schachter

Articles citing this

The rôle of Chlamydia trachomatis in genital-tract and associated diseases. J Clin Pathol (1980) 6.42

Laboratory diagnosis of human chlamydial infections. Clin Microbiol Rev (1989) 4.24

Screening for chlamydial infections in women attending family planning clinics. West J Med (1983) 3.51

CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun (1995) 3.45

Failure of serology in diagnosing chlamydial infections of the female genital tract. J Clin Microbiol (1979) 3.27

Evaluation of chlamydiazyme for the detection of genital infections caused by Chlamydia trachomatis. J Clin Microbiol (1986) 2.90

Comparison of monoclonal antibody staining and culture in diagnosing cervical chlamydial infection. J Clin Microbiol (1986) 2.80

Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76

Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect Immun (2005) 2.72

Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother (1980) 2.55

Comparison of the Syva MicroTrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population. J Clin Microbiol (1993) 2.35

In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. Antimicrob Agents Chemother (1987) 2.21

Chlamydia trachomatis elementary bodies possess proteins which bind to eucaryotic cell membranes. J Bacteriol (1986) 2.08

Contact-tracing in patients with genital chlamydial infection. Br J Vener Dis (1980) 2.07

Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03

A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci U S A (1996) 1.87

Colonisation of pregnant and puerperal women and neonates with Chlamydia trachomatis. Br J Vener Dis (1980) 1.85

Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect Immun (1997) 1.84

Characterization of Chlamydia DNA by restriction endonuclease cleavage. Infect Immun (1983) 1.81

Therapeutic abortion and chlamydial infection. Br Med J (Clin Res Ed) (1983) 1.79

Chlamydial infections. West J Med (1990) 1.79

Generation of targeted Chlamydia trachomatis null mutants. Proc Natl Acad Sci U S A (2011) 1.77

Human cell-mediated immune responses to chlamydial antigens. Infect Immun (1979) 1.76

Failure to detect cell-mediated cytotoxicity against Chlamydia trachomatis-infected cells. Infect Immun (1983) 1.71

A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J Exp Med (2011) 1.70

Chlamydia trachomatis in acute salpingitis. Br J Vener Dis (1979) 1.69

Persistent infection of mouse fibroblasts (McCoy cells) with a trachoma strain of Chlamydia trachomatis. Infect Immun (1981) 1.64

Chlamydia trachomatis infections in women with urogenital symptoms. Can Med Assoc J (1982) 1.63

Immunoassay for detecting Chlamydia trachomatis major outer membrane protein. J Clin Microbiol (1983) 1.61

Ophthalmia neonatorum in the 1980s: incidence, aetiology and treatment. Br J Ophthalmol (1982) 1.59

Therapeutic abortion and Chlamydia trachomatis infection. Br J Vener Dis (1982) 1.53

Reticulate bodies as single antigen in Chlamydia trachomatis serology with microimmunofluorescence. J Clin Microbiol (1979) 1.50

Provision of a chlamydial culture service to a sexually transmitted diseases clinic. Br J Vener Dis (1982) 1.46

Developmental-form-specific DNA-binding proteins in Chlamydia spp. Infect Immun (1988) 1.43

Systemic Chlamydia trachomatis infection in mice: a comparison of lymphogranuloma venereum and trachoma biovars. Infect Immun (1985) 1.42

Chlamydial gene encoding a 70-kilodalton antigen in Escherichia coli: analysis of expression signals and identification of the gene product. J Bacteriol (1989) 1.39

General and Family Practice: Chlamydia trachomatis Infections. West J Med (1984) 1.39

Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro. Antimicrob Agents Chemother (1985) 1.38

Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun (1991) 1.38

Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. Infect Immun (1999) 1.35

Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. J Immunol (2009) 1.33

Persistence of chlamydial antibodies after pelvic inflammatory disease. J Clin Microbiol (1986) 1.29

Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses. Infect Immun (2000) 1.23

Chlamydia trachomatis stimulates human peripheral blood B lymphocytes to proliferate and secrete polyclonal immunoglobulins in vitro. Infect Immun (1984) 1.15

Spectrum of human chlamydial infections. West J Med (1981) 1.13

Indirect immunofluorescence staining of Chlamydia trachomatis inclusions in microculture plates with monoclonal antibodies. J Clin Microbiol (1984) 1.13

Experimental infection of the marmoset genital tract with Chlamydia trachomatis. Br J Exp Pathol (1980) 1.12

Kinetics of chlamydial antigen processing and presentation to T cells by paraformaldehyde-fixed murine bone marrow-derived macrophages. Infect Immun (1995) 1.10

Rapid diagnosis of Chlamydia trachomatis infection in patients attending an ophthalmic casualty department. Br J Ophthalmol (1986) 1.10

Subclinical pneumonia due to serotypes D-K of Chlamydia trachomatis. Case reports of two infants. Br J Vener Dis (1980) 1.09

Reactivation of Chlamydia trachomatis lung infection in mice by cortisone. Infect Immun (1983) 1.07

Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies. Infect Immun (1995) 1.06

Roles of Ca2+ and F-actin in intracellular aggregation of Chlamydia trachomatis in eucaryotic cells. Infect Immun (1993) 1.03

Enzyme-linked immunosorbent assay for immunoglobulin G and M antibodies to Chlamydia trachomatis in human sera. J Clin Microbiol (1983) 1.00

Use of a Chlamydia trachomatis DNA probe for detection of ocular chlamydiae. J Clin Microbiol (1989) 0.99

In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis. Antimicrob Agents Chemother (1992) 0.98

Treatment of uncomplicated anogenital gonorrhoea with a single oral dose of 3 g amoxycillin combined with 250 mg clavulanic acid. Br J Vener Dis (1984) 0.98

Cell-mediated and humoral immune responses to chlamydial antigens in guinea pigs infected ocularly with the agent of guinea pig inclusion conjunctivitis. Infect Immun (1981) 0.97

T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development. Can J Infect Dis (1998) 0.94

Cyclic AMP inhibits developmental regulation of Chlamydia trachomatis. J Bacteriol (1986) 0.94

Bacterial infection in the newborn. Br Med J (1980) 0.91

Suppression of Chlamydia trachomatis inclusion formation by fetal calf serum in cycloheximide-treated McCoy cells. J Clin Microbiol (1980) 0.91

Detection of antichlamydial immunoglobulin G and M antibodies by enzyme-linked immunosorbent assay. J Clin Microbiol (1983) 0.91

Chlamydial antigens stabilized with formalin for use in the micro-immunofluorescence test. J Clin Microbiol (1980) 0.90

Accuracy of immunoglobulin M immunoassay for diagnosis of chlamydial infections in infants and adults. J Clin Microbiol (1986) 0.90

Cytotoxic and immunoregulatory function of intestinal lymphocytes in Chlamydia trachomatis proctitis of nonhuman primates. Infect Immun (1987) 0.89

Chlamydia trachomatis and pneumonia in infants: report of two cases. Can Med Assoc J (1978) 0.89

A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic. Infect Immun (1993) 0.89

Less inhibition of interferon-gamma to organism growth in host cells may contribute to the high susceptibility of C3H mice to Chlamydia trachomatis lung infection. Immunology (2004) 0.89

Immunoprophylaxis of Chlamydia trachomatis lymphogranuloma venereum pneumonitis in mice by oral immunization. Infect Immun (1989) 0.89

T cell proliferative responses to Chlamydia trachomatis antigen in vitro in patients with a history of gynaecological chlamydia infection. Br J Vener Dis (1984) 0.88

Chlamydia trachomatis polymorphic membrane protein D is a virulence factor involved in early host-cell interactions. Infect Immun (2014) 0.87

Sulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo murine model of chlamydial genital tract infection. Infect Immun (1998) 0.85

Evaluation of chlamydiazyme enzyme immunoassay for detection of Chlamydia trachomatis in urine specimens from men. J Clin Microbiol (1993) 0.84

Comparison of buffalo green monkey cells and McCoy cells for isolation of Chlamydia trachomatis in a microtiter system. J Clin Microbiol (1989) 0.84

Criteria for development of animal models of diseases of the reproductive system. Am J Pathol (1980) 0.83

Psittacosis. West J Med (1987) 0.83

Clinically silent infections in patients with oligoarthritis: results of a prospective study. Ann Rheum Dis (1992) 0.81

Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection. Mol Med (2013) 0.81

Infectivity of Chlamydia trachomatis in tissue culture with newborn calf serum. J Clin Microbiol (1982) 0.81

Use of the Cytobrush for concurrent endocervical cytology and chlamydia sampling. Genitourin Med (1990) 0.80

Antibody signature of spontaneous clearance of Chlamydia trachomatis ocular infection and partial resistance against re-challenge in a nonhuman primate trachoma model. PLoS Negl Trop Dis (2013) 0.80

Acute Chlamydia trachomatis respiratory infection in infants. J Glob Infect Dis (2011) 0.79

Epidemiologic and clinical factors of Chlamydia trachomatis in black, Hispanic and white female adolescents. West J Med (1985) 0.78

Diagnosis and treatment of urethritis in men. Yale J Biol Med (1983) 0.75

Chlamydia infect the placenta less often than gonococci. Genitourin Med (1988) 0.75

Isolation of Chlamydia trachomatis in Untreated MMC-E mouse epithelial cells. J Clin Microbiol (1982) 0.75

Preventive medicine and public health: clinical basis for treating presumptive chlamydial infection. West J Med (1985) 0.75

Vaginal discharge: an approach to diagnosis and management. Can Fam Physician (1987) 0.75

Immune Protection Against Chlamydia trachomatis in Females. Infect Dis Obstet Gynecol (1996) 0.75

Neonatal chlamydia conjunctivitis. Br Med J (1978) 0.75

Single-dose trospectomycin for chlamydial urethritis in men. Antimicrob Agents Chemother (1991) 0.75

Growth of host cells and Chlamydia trachomatis in medium containing serum from 16-week-old calves. J Clin Microbiol (1983) 0.75

Cervical cytology and Chlamydia trachomatis infection. Arch Gynecol (1983) 0.75

Obstetrics and gynecology-epitomes of progress: chlamydial infections in obstetrics and gynecology. West J Med (1981) 0.75

Pathology-epitomes of progress: the role of Chlamydia in sexually transmitted diseases. West J Med (1982) 0.75

Anorectal and enteric infections in homosexual men. West J Med (1985) 0.75

Stimulation of peroxidase by chlamydial infection: cytochemistry of guinea pig conjunctival epithelium. Infect Immun (1979) 0.75

Global survey of mRNA levels and decay rates of Chlamydia trachomatis trachoma and lymphogranuloma venereum biovars. Heliyon (2017) 0.75

Articles by these authors

(truncated to the top 100)

Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13

Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet (1995) 7.46

Chlamydial infections (first of three parts). N Engl J Med (1978) 5.79

Chlamydiae. Annu Rev Microbiol (1980) 5.47

Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis. Infect Immun (1984) 5.00

Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol (2001) 4.92

Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect Immun (1982) 4.82

Are chlamydial infections the most prevalent venereal disease? JAMA (1975) 4.79

Severe endemic trachoma in Tunisia. Br J Ophthalmol (1976) 4.35

Chlamydial infections. Annu Rev Med (1981) 3.94

Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93

Screening for chlamydial infections in women attending family planning clinics. West J Med (1983) 3.51

Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50

Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44

Chlamydial infections (second of three parts). N Engl J Med (1978) 3.40

Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis (1992) 3.30

Failure of serology in diagnosing chlamydial infections of the female genital tract. J Clin Microbiol (1979) 3.27

Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. J Infect Dis (1981) 3.19

The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. Plasmid (1990) 3.08

Prevalence of urethral Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic, sexually active adolescent boys. J Infect Dis (1987) 3.02

The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med (1994) 2.92

The association between Chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control study. JAMA (1990) 2.91

Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. JAMA (1989) 2.87

Immunodiagnosis of sexually transmitted disease. Yale J Biol Med (1986) 2.82

The venereal nature of inclusion conjunctivitis. Am J Epidemiol (1967) 2.80

Comparison of monoclonal antibody staining and culture in diagnosing cervical chlamydial infection. J Clin Microbiol (1986) 2.80

Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol (2000) 2.80

Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80

Prospective study of chlamydial infection in neonates. Lancet (1979) 2.80

The role of antibody in host defense against the agent of mouse pneumonitis. J Infect Dis (1982) 2.78

Lymphogranuloma venereum. II. Characterization of some recently isolated strains. J Bacteriol (1969) 2.78

Rapid diagnosis of sexually transmitted diseases--speed has a price. Diagn Microbiol Infect Dis (1986) 2.69

Latrine ownership as a protective factor in inflammatory trachoma in Egypt. Br J Ophthalmol (1991) 2.67

Topical tetracycline and rifampicin therapy of endemic trachoma in Tunisia. Am J Ophthalmol (1975) 2.66

Confirmatory assay increases specificity of the chlamydiazyme test for Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1990) 2.65

Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother (1980) 2.55

A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun (1990) 2.55

Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis (1991) 2.35

Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34

Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice. Infect Immun (1988) 2.30

Cellular immunity to the mouse pneumonitis agent. J Infect Dis (1984) 2.28

Comparison of the major outer membrane protein variant sequence regions of B/Ba isolates: a molecular epidemiologic approach to Chlamydia trachomatis infections. J Infect Dis (1992) 2.21

Inhibition of antichlamydial IgM antibody by IgG antibody in immunofluorescence tests. J Immunol (1972) 2.20

Isolation of bedsoniae from the joints of patients with Reiter's syndrome. Proc Soc Exp Biol Med (1966) 2.17

An animal model of trachoma II. The importance of repeated reinfection. Invest Ophthalmol Vis Sci (1982) 2.16

Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infections and histopathology in San Francisco. J Infect Dis (1995) 2.12

Why we need a program for the control of Chlamydia trachomatis. N Engl J Med (1989) 2.12

Evaluation of urine-based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males. JAMA (1993) 2.12

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis (1996) 2.12

Chlamydia trachomatis: important relationships to race, contraception, lower genital tract infection, and Papanicolaou smear. J Pediatr (1984) 2.11

Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol (1987) 2.11

Plaque formation by Chlamydia in L cells. Infect Immun (1970) 2.09

A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest (1993) 2.09

The intracellular life of Chlamydia. Curr Top Microbiol Immunol (1988) 2.09

Multiple-antigen slide test for detection of immunoglobulin M antibodies in newborn and infant sera by immunofluorescence. J Clin Microbiol (1981) 2.07

Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA (1986) 2.06

NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. Sex Transm Dis (2000) 2.05

Enzyme immunoassay for diagnosis of gonorrhea. J Clin Microbiol (1984) 2.03

Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens. J Infect Dis (1990) 2.02

Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02

Chlamydia trachomatis-induced salpingitis in mice. J Infect Dis (1983) 1.99

Pneumonitis following inclusion blennorrhea. J Pediatr (1975) 1.95

Screening for Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent males: value of first-catch urine examination. Lancet (1984) 1.91

Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases? Arch Pediatr Adolesc Med (1999) 1.91

Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis (1995) 1.86

Cytobrush in collection of cervical specimens for detection of Chlamydia trachomatis. J Clin Microbiol (1989) 1.84

Amoxicillin therapy for Chlamydia trachomatis in pregnancy. Obstet Gynecol (1990) 1.83

Microbiology of the lower genital tract in postmenarchal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis. J Pediatr (1985) 1.81

Evaluation of laboratory methods for detecting acute TRIC agent infection. Am J Ophthalmol (1970) 1.77

Antibiotic susceptibility of Chlamydia trachomatis. Antimicrob Agents Chemother (1977) 1.76

Serotyping of Chlamydia. I. Isolates of ovine origin. Infect Immun (1974) 1.76

Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73

Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol (1980) 1.71

Failure to detect cell-mediated cytotoxicity against Chlamydia trachomatis-infected cells. Infect Immun (1983) 1.71

Trachoma and blindness in the Nile Delta: current patterns and projections for the future in the rural Egyptian population. Br J Ophthalmol (1989) 1.66

Plaque reduction technique for demonstrating neutralizing antibodies for Chlamydia. Infect Immun (1970) 1.63

Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis. Sex Transm Dis (1996) 1.63

Serotyping of Chlamydia: isolates of bovine origin. Infect Immun (1975) 1.61

The medical and psychosocial needs of children entering foster care. Child Abuse Negl (1987) 1.61

Immunoassay for detecting Chlamydia trachomatis major outer membrane protein. J Clin Microbiol (1983) 1.61

The etiology of nongonococcal urethritis in men attending a venereal disease clinic. Sex Transm Dis (1977) 1.60

Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse. J Infect Dis (1987) 1.59

Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect Immun (1989) 1.58

A Bedsonia isolated from a patient with clinical lymphogranuloma venereum. Am J Ophthalmol (1967) 1.57

Role of CD8 T cells in primary Chlamydia infection. Infect Immun (1995) 1.56

Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection. Infect Immun (1988) 1.56

Chlamydiae as agents of sexually transmitted diseases. Bull World Health Organ (1976) 1.55

Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection. Infect Immun (1989) 1.54

Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol (1979) 1.52

Failure to identify venereal disease in a lesbian population. Sex Transm Dis (1981) 1.52

Lymphogranuloma venereum. I. Comparison of the Frei test, complement fixation test, and isolation of the agent. J Infect Dis (1969) 1.52

Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over. J Clin Oncol (2000) 1.51

Inclusion conjunctivitis in the guinea pig. Am J Ophthalmol (1967) 1.51

Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. Bull World Health Organ (2003) 1.49

Cytology as a guide to the presence of chlamydial inclusions in Giemsa-stained conjunctival smears in severe endemic trachoma. Br J Ophthalmol (1975) 1.47

Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun (1984) 1.47

Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA (1983) 1.46

Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. Bull World Health Organ (1999) 1.44

An animal model for cicatrizing trachoma. Invest Ophthalmol Vis Sci (1981) 1.44

Chlamydial infection in women with cervical dysplasia. Am J Obstet Gynecol (1975) 1.44